IPIRA Startups

IPIRA Startups

Sift Biosciences

Brief Description

Sift Biosciences supercharges existing cancer therapies by leveraging artificial intelligence and high-throughput cellular screening to discover and design immunotherapy boosters that significantly extend cancer patient survival. The company was co-founded by Yue Clare Lou (BS ’18 Microbial Biology; PhD ’23 Microbiology) and Maddie Williams (PhD student '23-present, Molecular & Cell Biology) to commercize technology developed during their doctoral research at UC Berkeley.

Inventors

Yue "Clare" Lou, Madeline Dee Williams

Company Founders

Yue "Clare" Lou (...

Tessera Therapeutics, Inc.

Brief Description

Developer of gene writing technology designed to permanently make small and large alterations to the human genome. The company's technology helps scientists and clinicians with the ability to write small and large therapeutic messages into the genome to treat diseases at their source, enabling healthcare providers to cure their patients and improve their lives.

Tessera Scientific Advisory Board Member David Schaffer co-invented the company's foundational technology as UC Berkeley Professor of Chemical and Biomolecular Engineering, Bioengineering, Molecular and Cell...

Scribe Therapeutics

Brief Description

Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders. The molecular engineering company was spun out of discoveries in the lab of UC Berkeley Professor of Biochemistry, Biophysics and Structural Biology and Nobel Laureate Jennifer Doudna. Doudna co-founded Scribe with company CEO Benjamin Oakes, who received a PhD in Molecular and Cellular Biology from UC Berkeley in 2017, where he worked in the Doudna Lab and Savage Lab, UC Berkeley Associate Professor of...

Fixation Bio

Brief Description

Fixation Bio is on a mission to shape the future of agriculture by optimizing photosynthesis to improve plants’ ability to assimilate CO2 and adapt to future atmospheric conditions.

Inventors

David Frank Savage, Noam Prywes, Abraham Isser Flamholz

Company Founders

Noam Prywes (UC Berkeley postdoc), Jake Wintermute

Timeline 2025. Company founded

GigaCrop

Brief Description

Manufacturer of bio-derived hydrogen peroxide using synthetic biology intended to make photosynthesis better. The company engineers enzymes that are used instead of traditional chemical catalysts to remove organic solvents during the production of hydrogen peroxide, allowing the process to occur in any environment while reducing carbon emissions.

GigaCrop Founder and CEO Dr. Christopher Eiben earned his PhD in bioengineering at UC Berkeley, focusing on synthetic metabolism and protein engineering in the lab of UC Berkeley Professor Dr. Jay Keasling, a pioneer in...

Global Newborn Solutions, Inc.

Brief Description

Global Newborn Solutions (GNS) develops medical innovations to address the most vital components of neonatal health and survival in resource-limited settings.

​GNS has commercialized an infant warming device called the Dream Warmer, which was invented by UC Berkeley and LBNL researchers to save the lives of infants suffering from hypothermia in low income countries, where premature and low-birth weight infants are particularly at risk. The wrap-around pad keeps infants warm. It contains a phase-change material, which is a substance that can absorb and release large...

GenoptX, LLC

Brief Description

A CRISPR-based gene editing company.

Formerly known as Syncodi.

Inventors

Jennifer Doudna, Abraham Isser Flamholz, Dana Nadler, Benjamin Oakes, David Frank Savage

Timeline 2019. Company founded.

Genocea Biosciences, Inc.

Brief Description

Genocea finds targets of T cell responses to discover and develop life-changing medicines. The company created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system, which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases. Genocea designs its medicines using ATLASª, a proprietary technology platform. Genocea's platform has the potential to revolutionize vaccines and immunotherapies for a range of infectious diseases, cancers and autoimmune diseases. The...

Generation Lab

Brief Description

Generation Lab provides the first and only platform that measures the effectiveness of longevity interventions to identify what works. Co-founded by pre-eminent aging and longevity researcher Dr. Irina Conboy from UC Berkeley, Generation Lab combines an easy-to-use test with proprietary techniques to definitively measure molecular disbalance that indicates aging and risk of disease before symptoms arise. The company works with clinicians who can recommend personalized interventions to increase health, wellness, and longevity; and Generation Lab uniquely measures the...

Geneditor Biosciences, Inc.

Brief Description

Geneditor Biosciences is a pre-clinical stage gene editing company focused on the treatment of rare cancers with unmet medical needs.

Inventors

Jennifer Doudna

Company Founders

Jennifer Doudna

Timeline 2021. Company founded.